Nancy the Dachshund

See how rapid, point-of-care molecular diagnostics could have improved patient outcome.

Read the story of how Nancy the Dachshund did not receive the correct treatment due to the lag-time to receive lab results, and how LexaGene’s LX6 could have prevented this scenario.